Navigation Links
HYCOR Expands Board of Directors to Support Growth in Key Areas
Date:5/16/2011

GARDEN GROVE, Calif., May 16, 2011 /PRNewswire/ -- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets, together with owner Linden, LLC, today announced the appointments of Vijay Aggarwal, Ph.D. and James Koziarz, Ph.D., to its Board of Directors as part of its global growth strategy.  

"We are thrilled to welcome Drs. Aggarwal and Koziarz to the HYCOR team and are confident they will have meaningful impact in areas critical for the company's continued growth," said Richard Novak, Chairman of HYCOR's Board of Directors, and Operating Partner at Linden, LLC. "Both of these gentlemen have extensive backgrounds in clinical diagnostics for market leading companies, and we are certain that HYCOR will benefit from their guidance in the near and long term."  

Dr. Aggarwal brings more than 30 years of experience and leadership in the pharmaceutical and diagnostics industries, having served in senior management positions for a number of leading companies, including Quest Diagnostics, IBT Laboratories and SmithKline Beecham. As Director, Dr. Aggarwal will support the HYCOR management team in a variety of capacities with a particular focus on channel development in clinical laboratories.

Dr. Koziarz joins HYCOR's Board after a distinguished 25 year career at Abbott Laboratories, where he held several senior management and executive positions, including Corporate Vice President for Diagnostic Products Research & Development. Dr. Koziarz is also an active advisor to several leading life sciences companies. As Director, Dr. Koziarz will support the HYCOR management team on next generation assay and platform development strategies for global customers.    

"We are pleased to have the opportunity to partner with these two leaders in clinical diagnostics and are confident it will benefit HYCOR, the healthcare professionals and patients our products serve," said Dick Aderman, CEO, HYCOR. "Our executive team has begun working with each of them on key initiatives currently underway and we look forward to the value they will bring to our business."

HYCOR's CEO, Dick Aderman, also brings extensive leadership in the clinical diagnostics arena, having spent more than 30 years serving in senior management positions for a number of clinical diagnostic companies, including Roche Diagnostics Corporation, Boehringer Mannheim Corporation and Dade International.

About HYCOR Biomedical, Inc.

Founded in 1981, HYCOR is a global manufacturer and marketer of in vitro diagnostics products. Since its founding, HYCOR has expanded its presence into urinalysis, allergy and autoimmune products used in clinical laboratories, hospitals and doctors' offices worldwide. Among its products, HYCOR markets the HYTEC™, KOVA® and AUTOSTAT™ brands. The company is focused on delivering products that provide the highest value to clinicians through innovation, reliability and customer service. For more information, please visit www.hycorbiomedical.com.

About Linden LLC

Linden is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden's portfolio includes BarrierSafe Solutions International, Behavioral Centers of America, Corpak MedSystems, Drayer Physical Therapy Institute, HYCOR Biomedical, and Ranir. For additional information, please visit www.lindenllc.com.


'/>"/>
SOURCE HYCOR Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Isis Earns $3 Million Payment as Collaboration With GSK Expands
2. Hill-Rom Increases Third Quarter Dividend and Expands Stock Repurchase
3. Wilson Sonsini Goodrich & Rosati Expands IP Litigation Practice
4. FDA Expands Approved Use For Carotid Stent
5. Echo Therapeutics Expands Into New Headquarters in Philadelphia
6. BAETA Corp. Expands Market Awareness Programs
7. Optimer Pharmaceuticals Expands Senior Management Team
8. MedPro Imaging Expands Operations With Opening of Dedicated Advanced Transducer Repair Facility
9. DC Electronics Expands Facilities to Increase Capacity
10. Millstone Medical Outsourcing Expands Sales, Marketing Capacity, Hires Two Professionals
11. Transgenomic, Inc. Expands SURVEYOR® Scan Product Line With BRAF and PIK3CA Mutation Detection Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2, 2016  UCB is pleased to announce that 12 scientific ... 70 th American Epilepsy Society (AES) Annual Meeting, which ... , USA. 1-12 Data being ... of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... the current state of the union of epilepsy care and ...
(Date:12/2/2016)... , December 2, 2016 The iShares ... past losses following Trump,s victory early in November. Less ... fund managers are now predicting an uptick in M&A ... equities to see how they have fared at the ... ), Amicus Therapeutics Inc. (NASDAQ: FOLD ), ...
(Date:11/30/2016)... -- Research and Markets has announced the addition of ... report to their offering. ... Detachable coil embolization is a minimally ... detachable coil embolization treatment of cerebral aneurysms is less invasive and requires ... in the wall of an artery in the brain. This area bulges ...
Breaking Medicine Technology:
(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility Centers ... as a Cigna Infertility Center of Excellence. The Cigna Center of Excellence recognizes ... an honor to be designated a Cigna Infertility Center of Excellence," said Fertility ...
(Date:11/30/2016)... , ... November 30, 2016 , ... "I hate when ... arm while brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that ... develop this handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and ...
(Date:11/30/2016)... FL (PRWEB) , ... November 30, 2016 , ... ... disorder and mental health treatment has announced the opening of a new eating ... partial hospitalization and intensive outpatient treatment for adults and adolescents, both males and ...
(Date:11/30/2016)... ... November 30, 2016 , ... In recent policy debates, increasing ... public policymakers and system stakeholders in many states. To help them understand this ... Index for Workers’ Compensation, Eighth Edition (MPI-WC) . , “If you are a ...
(Date:11/30/2016)... ... 30, 2016 , ... The Clinical Data Interchange Standards Consortium ... Guidance goes into effect next month. Sponsors whose studies start after December 17, ... Catalog. The current FDA Data Standards Catalog specifies the use of CDISC standards: ...
Breaking Medicine News(10 mins):